Alnylam Pharmaceuticals Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan '26 Jan 29, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	32,555	24,243	18,858	24,266	14,979	11,060
Market Cap Growth	23.05%	28.56%	-22.29%	62.00%	35.43%	14.08%
Enterprise Value	32,590	24,200	19,060	24,537	14,677	10,722
Last Close Price	249.24	190.55	151.59	191.34	119.22	99.03
PS Ratio	13.63	13.50	13.14	28.18	24.02	30.64
PB Ratio	187.09	452.40	-108.87	-184.79	34.48	14.86
P/TBV Ratio	187.09	452.40	-	-	34.48	14.86
P/FCF Ratio	197.68	-	572.67	-	-	-
P/OCF Ratio	164.60	-	230.62	-	-	-
EV/Sales Ratio	13.93	13.48	13.28	28.50	23.54	29.70
EV/FCF Ratio	197.90	-	578.81	-	-	-
Debt / Equity Ratio	11.86	40.89	-12.16	-16.51	3.72	1.57
Debt / FCF Ratio	12.53	-	63.96	-	-	-
Asset Turnover	0.71	0.56	0.50	0.29	0.24	0.17
Inventory Turnover	6.83	3.86	2.85	1.57	1.74	1.19
Quick Ratio	2.37	2.61	2.86	3.17	3.79	4.23
Current Ratio	2.54	2.78	3.08	3.51	4.04	4.47
Return on Equity (ROE)	32.73%	-	-	-526.14%	-106.31%	-69.92%
Return on Assets (ROA)	3.65%	-2.74%	-4.78%	-13.65%	-12.56%	-17.85%
Return on Capital Employed (ROCE)	8.00%	-5.80%	-9.90%	-28.30%	-24.00%	-29.40%
Earnings Yield	0.10%	-0.92%	-1.83%	-3.87%	-4.21%	-5.68%
FCF Yield	0.51%	-0.14%	0.18%	-2.10%	-3.54%	-4.54%
Buyback Yield / Dilution	-4.82%	-2.20%	-2.64%	-2.73%	-3.01%	-5.24%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.